The Diabetes Research Center (DRC) of the University of Pennsylvania is now accepting applications for support to perform pilot and feasibility (P&F) studies in diabetes and related endocrine and metabolic disorders. 

The application deadline is Monday, December 12, 2022, by 5 p.m.

The P&F program is intended to support new investigators and established investigators new to diabetes research. Established diabetes investigators pursing high impact/high risk projects or projects that are a significant departure from their usual work are also eligible for support under the DRC P&F program. Applications are welcome from basic, clinical, and translational investigators.

Grants will be reviewed by the DRC Pilot and Feasibility Review Committee, as well as internal and external reviewers. Funding level maximum is $50,000. 

For detailed information and instructions: https://www.med.upenn.edu/idom/drc/pilots.html.

Investigators who are currently in the first year of support through this P&F program may reapply for an additional year of funding. Continuation requests need to be carefully justified and will be considered as competing renewals.

For more information, contact Lisa Henry at henryli@pennmedicine.upenn.edu; Patrick Seale, director, DRC Pilot & Feasibility Grants Program, at sealep@pennmedicine.upenn.edu; or Doris Stoffers, associate director, DRC Pilot & Feasibility Grants Program, at stoffers@pennmedicine.upenn.edu.